Search Tag: AI in oncology
2025 16 Aug
Colorectal cancer is among the most common gastrointestinal malignancies and is the third leading cause of cancer-related mortality worldwide. Stage II disease is characterised by tumours that have not yet spread to lymph nodes or distant organs. Surgery is the primary treatment, yet recurrence occurs in 20–25% of patients after resection, often...Read more
2025 25 Mar
The classification of human epidermal growth factor receptor 2 (HER2) expression in breast cancer has undergone significant transformation with the identification of HER2-low as a distinct category. Traditional assessment methods using immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are invasive, costly and time-consuming,...Read more
2025 25 Mar
The classification of human epidermal growth factor receptor 2 (HER2) expression in breast cancer has undergone significant transformation with the identification of HER2-low as a distinct category. Traditional assessment methods using immunohistochemistry (IHC) and fluorescence in situ hybridisation (FISH) are invasive, costly and time-consuming,...Read more
2025 25 Mar
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in diagnostic and therapeutic approaches, the prognosis for patients with advanced HCC remains poor, with five-year survival rates as low as 18%. A major contributing factor...Read more
2025 25 Mar
Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in diagnostic and therapeutic approaches, the prognosis for patients with advanced HCC remains poor, with five-year survival rates as low as 18%. A major contributing factor...Read more
2025 17 Mar
Lung cancer is the leading cause of cancer-related deaths globally, resulting in over 1.8 million fatalities each year. Early detection through low-dose computed tomography (LDCT) screening significantly improves survival rates by identifying malignancies early. While screening benefits are well-recognised, large-scale implementation poses challenges,...Read more
2025 17 Mar
Lung cancer is the leading cause of cancer-related deaths globally, resulting in over 1.8 million fatalities each year. Early detection through low-dose computed tomography (LDCT) screening significantly improves survival rates by identifying malignancies early. While screening benefits are well-recognised, large-scale implementation poses challenges,...Read more
2025 10 Mar
The development of artificial intelligence in cancer research relies on access to extensive, high-quality imaging datasets. However, data fragmentation, heterogeneity and privacy concerns present significant challenges. The EUropean Federation for CAncer IMages (EUCAIM) initiative aims to overcome these obstacles by establishing a federated European...Read more
2025 10 Mar
Accurate preoperative classification of gastric cancer (GC) is essential for determining appropriate treatment strategies. The Lauren classification system categorises GC into intestinal and diffuse types, influencing both prognosis and therapeutic approaches. While conventional diagnostic methods, such as endoscopic biopsy, provide histological...Read more
2024 09 Dec
Colorectal cancer (CRC) is a significant global health challenge, being the third most prevalent malignancy and the second leading cause of cancer-related mortality. A primary complication in CRC management is the development of liver metastases, which affect approximately 50% of patients, either postoperatively or during later stages of the disease....Read more
2024 16 Nov
Ovarian cancer (OC) remains a critical health issue globally, particularly as the fifth leading cause of cancer-related deaths among women. Despite its prevalence, OC is often diagnosed at advanced stages, which reduces the chances of successful treatment and survival. In 2020 alone, approximately 314,000 new cases were reported worldwide, underscoring...Read more
2024 16 Nov
Ovarian cancer (OC) remains a critical health issue globally, particularly as the fifth leading cause of cancer-related deaths among women. Despite its prevalence, OC is often diagnosed at advanced stages, which reduces the chances of successful treatment and survival. In 2020 alone, approximately 314,000 new cases were reported worldwide, underscoring...Read more